Finance

Lists
Why is IVA up 9.40%?
Dive Deeper
IVA:NASDAQ
Inventiva SA - ADR
$3.26
+9.40%
(+0.28) 1D
$3.24
-0.61% (-0.020)
Pre-market
Closed: Oct 20, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IVA...
Open
$3.00
High
$3.36
Low
$3.00
Mkt. cap
791.50M
Avg. vol.
2.69M
Volume
1.52K
52-wk high
$7.98
52-wk low
$2.82
EPS
-$1.04
Beta
0.75
Shares outstanding
237.99M
No. of employees
87
Open
$3.00
High
$3.36
Low
$3.00
Mkt. cap
791.50M
Avg. vol.
2.69M
Volume
1.52K
52-wk high
$7.98
52-wk low
$2.82
EPS
-$1.04
Beta
0.75
Shares outstanding
237.99M
No. of employees
87
News stories
From web sources and news partners
About Inventiva SA - ADR
CEO-
Employees87
Founded2011
Headquarters-
SectorBiotechnology
Websiteinventivapharma.com
Analyst ratings
Based on 9 analysts giving stock ratings to IVA in the past 3 months
Strong buy
Buy
9
Hold
0
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for IVA in the last 3 months.
Highest
Current $3.26
$26.00 (+697.55%)
Average
$15.50 (+375.46%)
Lowest
$10.00 (+206.75%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$26.00
+697.5%
10/19/2026
Srikripa Devarakonda
Truist Financial
Buy
Reiterated
-
-
10/02/2026
Michael Yee
UBS
Buy
Maintained
$12.00
+268.1%
09/30/2026
Thomas Smith
Leerink Partners
Buy
Reiterated
$12.00
+268.1%
09/29/2026
Seamus Fernandez
Guggenheim
Buy
Reiterated
$14.00
+329.4%
09/28/2026
Edward Nash
Canaccord Genuity
Buy
Reiterated
$21.00
+544.2%
09/29/2026
Ritu Baral
TD Cowen
Buy
Maintained
$10.00
+206.7%
09/28/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$14.00
+329.4%
09/28/2026
Annabel Samimy
Stifel Nicolaus
Buy
Reiterated
$15.00
+360.1%
09/23/2026
Prakhar Agrawal
Cantor Fitzgerald
Buy
Initiated
-
-
07/17/2026
Eliana Merle
Barclays
Buy
Maintained
$18.00
+452.1%
06/04/2026
Ananda Ghosh
H.C. Wainwright
Buy
Maintained
$24.00
+636.2%
01/28/2026
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
575.50K
575.50K
652.50K
652.50K
Cost of goods sold
38.00K
38.00K
229.00K
229.00K
Cost of revenue
38.00K
38.00K
229.00K
229.00K
Research and development expenses
20.14M
20.14M
21.97M
21.97M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.86M
14.86M
11.46M
11.46M
Operating expense
39.16M
39.16M
35.25M
35.25M
Total operating expenses
39.20M
39.20M
35.48M
35.48M
Operating income
-38.62M
-38.62M
-34.83M
-34.83M
Other non operating income
-38.58M
-38.58M
5.30M
5.30M
EBT including unusual items
-88.87M
-88.87M
-34.68M
-34.68M
EBT excluding unusual items
-88.45M
-88.45M
-34.31M
-34.31M
Income tax expense
262.50K
262.50K
52.00K
52.00K
Effective tax rate
-0.30%
-0.30%
-0.15%
-0.15%
Other operating expenses
4.16M
4.16M
1.82M
1.82M
Net income
-89.13M
-89.13M
-34.73M
-34.73M
Net profit margin
-15,487.05%
-15,487.05%
-5,323.14%
-5,323.14%
Earnings per share
-
-
-
-
Interest and investment income
849.50K
849.50K
1.11M
1.11M
Interest expense
-11.92M
-11.92M
-7.23M
-7.23M
Net interest expenses
-11.07M
-11.07M
-6.12M
-6.12M
Depreciation and amortization charges
-
-
-
-
EBITDA
-38.04M
-38.52M
-34.05M
-34.05M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps